Apomorphine(Grupo Ferrer Internacional)

N/A

Report date: 2024/04/10 18:00:25

Base Information

Drug NameApomorphine(Grupo Ferrer Internacional)
Drug Alias NameApomorphine StaccatoFNP 150FNP-150
ClassificationSmall molecules > Heterocyclic drugsDrug and medical devices combination products
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrupo Ferrer Internacional Sa
China Registration ClassN/A

Develop Information

Active CompaniesGrupo Ferrer Internacional Sa
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A